Phathom Pharmaceuticals PHAT
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 11.77 | -423 | -30 | -12.22 | 240 | |
| 2025Q2 | 9.59 | -406 | -76 | -27.85 | 250 | |
| 2025Q1 | 6.27 | -338 | -94 | -28.05 | 294 | |
| 2024Q4 | 8.12 | -254 | -74 | -19.46 | 378 | |
| 2024Q3 | 18.08 | -187 | -86 | -24.23 | 387 | |
| 2024Q2 | 10.30 | -234 | -91 | -27.06 | 319 | |
| 2024Q1 | 10.62 | -149 | -83 | -21.51 | 356 | |
| 2023Q4 | 9.13 | -73 | -80 | -24.45 | 414 | |
| 2023Q3 | 10.37 | -18 | -43 | -17.23 | 237 | |
| 2023Q2 | 14.32 | 18 | -41 | -20.03 | 265 | |
| 2023Q1 | 7.14 | -90 | -38 | -24.49 | 144 | |
| 2022Q4 | 11.22 | -75 | -55 | -30.02 | 165 | |
| 2022Q3 | 11.08 | -26 | -51 | -24.60 | 202 | |
| 2022Q2 | 8.44 | -7 | -51 | -28.09 | 214 | |
| 2022Q1 | 13.61 | 38 | -73.81 | -41 | -24.03 | 149 |
| 2021Q4 | 19.67 | 72 | -40.80 | -36 | -17.15 | 189 |
| 2021Q3 | 32.10 | 103 | -31.12 | -37 | -16.55 | 228 |
| 2021Q2 | 33.85 | 132 | -24.66 | -37 | -15.86 | 215 |
| 2021Q1 | 37.56 | 164 | -19.43 | -35 | -12.87 | 246 |
| 2020Q4 | 33.22 | 194 | -30.64 | -54 | -20.43 | 295 |